Compare RDHL & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDHL | FGI |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 14.0M |
| IPO Year | N/A | 2022 |
| Metric | RDHL | FGI |
|---|---|---|
| Price | $1.06 | $5.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 71.8K | ★ 75.6K |
| Earning Date | 09-05-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $9,550,000.00 | ★ $135,654,095.00 |
| Revenue This Year | $381.91 | $3.80 |
| Revenue Next Year | N/A | $6.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 157.62 | 6.66 |
| 52 Week Low | $0.91 | $2.28 |
| 52 Week High | $6.80 | $12.62 |
| Indicator | RDHL | FGI |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 45.55 |
| Support Level | $0.91 | $5.51 |
| Resistance Level | $1.23 | $7.41 |
| Average True Range (ATR) | 0.07 | 0.84 |
| MACD | -0.01 | -0.19 |
| Stochastic Oscillator | 46.21 | 15.90 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.